Modulation of angiopoietin-like 3 expression

Details for Australian Patent Application No. 2011203986 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Crooke, Rosanne M.; Graham, Mark J.; Lee, Richard; Dobie, Kenneth W.

Agent Pizzeys

Pub. Number AU-A-2011203986

PCT Pub. Number WO2011/085271

Priority 61/293,604 08.01.10 US

Filing date 7 January 2011

Wipo publication date 14 July 2011

International Classifications

A61K 31/7105 - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

19 July 2012 PCT application entered the National Phase

  PCT publication WO2011/085271 Priority application(s): WO2011/085271

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203989-System for modifying eye tissue and intraocular lenses

2011203980-Multi-lumen central access vena cava filter apparatus and method of using same